3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
24
Phase NA
23
Phase 3
14
Phase 1
11
Phase 1/2
7
Phase EARLY_PHASE1
2
Phase 4
1
Phase 2/3
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Recurrence
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Head and Neck Neoplasms
1
Glioblastoma
1
Interventions
Zoledronic Acid
5
Bevacizumab
3
exemestane
2
Therapeutics
2
Standard of Care
2
Pamidronate
2
Oxaliplatin
2
Misoprostol
2
Magnetic Resonance Spectroscopy
2
Letrozole
2
Ibandronic Acid
2
Fulvestrant
2
Fluorouracil
2
Cetuximab
2
Capecitabine
2
vandetanib
1
palbociclib
1
liposomal doxorubicin
1
huaier
1
eribulin
1
enzalutamide
1
darolutamide
1
cabozantinib
1
aldesleukin
1
abemaciclib
1
Vindesine
1
Trastuzumab
1
Sugars
1
Stents
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplasm Metastasis
×
Radiosurgery
×
Clear all
NCT05900908
2025-04-10
PATHWAyS
GT Medical Technologies, Inc.
Phase 4
Withdrawn